In vitro, macrophages can eliminate various opsonized solid [159,160,161,162,163,164,165] and hematological cancer [64,156,166,167] cell types via ADCP, which can be further promoted by treatment with anti-CD47 mAbs. Here, CD47 is linked to hematopoietic and lymphoid cell neoplasm.